R.L. Benza

ACUTE AND CHRONIC THERAPEUTIC IMPACT OF A VASOPRESSIN ANTAGONIST IN CONGESTIVE HEART FAILURE (ACTIV IN CHF) INVESTIGATORS. EFFECTS OF TOLVAPTAN, A VASOPRESSIN ANTAGONIST, IN PATIENTS HOSPITALIZED WITH WORSENING HEART FAILURE: A RANDOMIZED CONTROLLED TRIAL

M Gheorghiade, Wendy A. Gattis, Caroline Martine Connor et al. · 2004 · 139 citations

Medicine, Cardiology, Pharmacotherapy +12

Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension

Aimee Doran, D. Dunbar Ivy, Robyn J. Barst et al. · International Journal of Clinical Practice · 2008 · 119 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Are there specific risk factors for fatal allograft vasculopathy? An analysis of over 7,000 cardiac transplant patients

M R Costanzo, Howard J. Eisen, Rhubell Brown et al. · The Journal of Heart and Lung Transplantation · 2001 · 21 citations

Medicine, Cardiology, Surgery +16